semaglutide cardiovascular outcomes news today 2025 study New Science Suggests Semaglutide Improves CV Outcomes Beyond Weight Loss Oral Semaglutide and Cardiovascular Outcomes

A new weight loss treatment is on the horizon, and its set to redefine the way we manage obesity and metabolic health: Retatrutide.

Effective semaglutide shots for weight loss.

WHO GLP-1 Treatments: The World Health Organization has issued new guidelines endorsing GLP-1 agonists as essential treatments for obesity, highlighting the urgent need for action against the rising global obesity epidemic affecting over one billion people and posing serious health risks.

While many users find the process effective and budget-friendly, some have reported issues with customer service and delivery delays.

Researchers conducted a massive pooled safety analysis of over 96,000 participants across 112 randomized clinical trials to compare those taking the medication against a placebo group